Inex Pharmaceuticals Report issue

For profit Phase 2
Founded: Vancouver BC Canada (1996)
Status: Defunct (2006)

Organization Overview

First Clinical Trial
2000
NCT00006383
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2000

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (1)

vincristine (oncovin) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Lymphoma (Phase 2)

Lymphoma, Non-Hodgkin (Phase 2)

Osteosarcoma (Phase 2)

Sarcoma (Phase 2)

Wilms Tumor (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 1